tiprankstipranks
pc:windw

Windward Bio

Basel, Basel-Stadt, Switzerland
windwardbio.com
Windward Bio is a clinical-stage drug development company based in Switzerland, focused on improving outcomes for individuals with advanced immunological diseases, particularly severe respiratory conditions. The company is developing a novel long-acting monoclonal antibody targeting the TSLP ligand and is building a discovery pipeline of long-acting bispecifics to address high unmet medical needs and reduce treatment burdens globally.

Leadership & Board

Current Number of Employees44
Current LinkedIn Followers3,504

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$200M
Total Amount Raised$200M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$200M
Latest Funding Amount$200M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Windward Bio had 44 employees as of May 18, 2026. The number of employees increased by 1 (2.33%) week-over-week.
44Latest Employee Count
1(2.33%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Windward Bio had 3,504 followers as of May 18, 2026. The number of followers increased by 102 (3.00%) week-over-week.
3,504Latest Followers Count
102(3.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 10, 2025
Series A
$200.00M

Investors

Investor Name
Funding Round

Related News and Analysis